Literature DB >> 2988687

Initial dose of enalapril in hypertension.

J Webster, D M Newnham, J C Petrie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988687      PMCID: PMC1415786          DOI: 10.1136/bmj.290.6482.1623

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  1 in total

1.  Factors related to first dose hypotensive effect of captopril: prediction and treatment.

Authors:  G P Hodsman; C G Isles; G D Murray; T P Usherwood; D J Webb; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12
  1 in total
  7 in total

1.  The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.

Authors:  N J Macdonald; A Sioufi; C A Howie; J R Wade; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

2.  Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.

Authors:  P C Waller; G T McInnes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazide.

Authors:  J Webster; D Newnham; O J Robb; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 5.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 6.  Changes in the renin-angiotensin-aldosterone axis in later life.

Authors:  J Belmin; B I Lévy; J B Michel
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

7.  Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.